CIK 0001231457
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
GENELUX Corp
Sign in to watch- Ticker
- GNLX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 805-267-9889
- Business address
- 2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE, CA, 91361
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $155,693
- in 6 filings
Net −$155,693. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-03 | Cappello Joseph Chief Technical Officer | Sale | −668 | $2.04 | $1K | 317,812 |
| 2026-08-31 | Cappello Joseph Chief Technical Officer | Sale | −10,257 | $2.74 | $28K | 318,480 |
| 2026-08-04 | Cappello Joseph Chief Technical Officer | Sale | −653 | $2.95 | $2K | 328,737 |
| 2026-06-16 | Cappello Joseph Chief Technical Officer | Grant or award | +174,841 | 329,390 | ||
| 2026-05-11 | Cappello Joseph Chief Technical Officer | Sale | −605 | $2.97 | $2K | 154,549 |
| 2026-03-24 | Cappello Joseph Chief Technical Officer | Sale | −906 | $2.42 | $2K | 155,154 |
| 2025-11-17 | Cappello Joseph Chief Technical Officer | Sale | −973 | $5.37 | $5K | 156,060 |
| 2025-09-01 | Cappello Joseph Chief Technical Officer | Returned to the company · Stock Option (Right to Buy) | −16,666 | 0 | ||
| 2025-09-01 | Cappello Joseph Chief Technical Officer | Grant or award · Stock Option (Right to Buy) | +16,666 | 16,666 | ||
| 2025-09-01 | Cappello Joseph Chief Technical Officer | Returned to the company · Stock Option (Right to Buy) | −80,000 | 0 | ||
| 2025-09-01 | Cappello Joseph Chief Technical Officer | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2025-09-01 | Cappello Joseph Chief Technical Officer | Returned to the company · Stock Option (Right to Buy) | −13,333 | 0 | ||
| 2025-09-01 | Cappello Joseph Chief Technical Officer | Grant or award · Stock Option (Right to Buy) | +13,333 | 13,333 | ||
| 2025-09-01 | Cappello Joseph Chief Technical Officer | Returned to the company · Stock Option (Right to Buy) | −65,000 | 0 | ||
| 2025-09-01 | Cappello Joseph Chief Technical Officer | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2025-08-27 | Cappello Joseph Chief Technical Officer | Grant or award | +107,500 | 159,766 | ||
| 2025-08-27 | Cappello Joseph Chief Technical Officer | Grant or award · Stock Option (Right to Buy) | +142,500 | 142,500 | ||
| 2025-08-21 | Cappello Joseph Chief Technical Officer | Sale | −1,270 | $3.33 | $4K | 158,496 |
| 2025-08-21 | Cappello Joseph Chief Technical Officer | Sale | −1,463 | $3.36 | $5K | 157,033 |
| 2025-05-12 | Cappello Joseph VP, Pharmaceutical Development | Sale | −4,737 | $2.92 | $14K | 52,266 |
Page 1 of 2 · 29 trades